Schalm SW - Search Results

1

Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.

Heijtink RA, Kruining J, Honkoop P, Kuhns MC, Hop WC, Osterhaus AD, Schalm SW. Heijtink RA, et al. Among authors: schalm sw. J Med Virol. 1997 Nov;53(3):282-7. J Med Virol. 1997. PMID: 9365897

2

Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.

Tang TJ, de Man RA, Kusters JG, Kwekkeboom J, Hop WC, van der Molen RG, Schalm SW, Janssen HL. Tang TJ, et al. Among authors: schalm sw. J Med Virol. 2004 Feb;72(2):215-22. doi: 10.1002/jmv.10565. J Med Virol. 2004. PMID: 14695662 Clinical Trial.

3

Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent.

van der Eijk AA, Niesters HG, Götz HM, Janssen HL, Schalm SW, Osterhaus AD, de Man RA. van der Eijk AA, et al. Among authors: schalm sw. J Clin Virol. 2004 Feb;29(2):92-4. doi: 10.1016/s1386-6532(03)00092-1. J Clin Virol. 2004. PMID: 14747026

4

Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

Janssen HL, Berk L, Schalm SW, Heijtink RA, Hess G, Rossol S, Meyer zum Buschenfelde KH, Chamuleau RA, Jansen PL, Reesink HW, et al. Janssen HL, et al. Among authors: schalm sw. Gut. 1992 Aug;33(8):1094-8. doi: 10.1136/gut.33.8.1094. Gut. 1992. PMID: 1398234 Free PMC article.

5

Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy.

de Man RA, Schalm SW, van der Heijden AJ, ten Kate FW, Wolff ED, Heijtink RA. de Man RA, et al. Among authors: schalm sw. J Hepatol. 1989 May;8(3):367-72. doi: 10.1016/0168-8278(89)90036-6. J Hepatol. 1989. PMID: 2471723

6

Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes.

Heijtink RA, Knol RM, Schalm SW. Heijtink RA, et al. Among authors: schalm sw. J Med Virol. 1989 Feb;27(2):151-4. doi: 10.1002/jmv.1890270216. J Med Virol. 1989. PMID: 2522147 Clinical Trial.

7

Long-term immune reactivity to pre-S(2)-antigen after acute hepatitis B infection.

Heijtink RA, de Wilde GA, van Hattum J, Schalm SW. Heijtink RA, et al. Among authors: schalm sw. J Med Virol. 1989 Feb;27(2):95-9. doi: 10.1002/jmv.1890270205. J Med Virol. 1989. PMID: 2646395

8

Long-term follow-up of antiviral combination therapy in chronic hepatitis B.

De Man RA, Schalm SW, Heijtink RA, Berk L, Den Ouden J, ten Kate FJ, Chamuleau RA, Reesink HW. De Man RA, et al. Among authors: schalm sw. Am J Med. 1988 Aug 29;85(2A):150-4. Am J Med. 1988. PMID: 3044080 Clinical Trial.

9

Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapy.

Heijtink RA, Smal P, ten Kate FJ, Kruining J, Schalm SW. Heijtink RA, et al. Among authors: schalm sw. Antiviral Res. 1987 Jul;7(6):329-40. doi: 10.1016/0166-3542(87)90015-5. Antiviral Res. 1987. PMID: 3674854

10

Quantitative relationship between HBeAg and DNA polymerase activity in sera from patients with chronic active hepatitis during a three-month period.

Heijtink RA, van der Waart M, Weimar W, Schalm SW, Masurel N. Heijtink RA, et al. Among authors: schalm sw. J Med Virol. 1980;5(4):295-302. doi: 10.1002/1096-9071(1980)5:4<295::aid-jmv1890050405>3.0.co;2-5. J Med Virol. 1980. PMID: 7229620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters